+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rivaroxaban Test"

2020 Rivaroxaban Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 Rivaroxaban Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • March 2020
  • Japan, United States, ... Japan, United States, Europe
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Rivaroxaban Test is a point-of-care diagnostic test used to measure the presence of the anticoagulant drug rivaroxaban in a patient's blood. It is used to monitor the effectiveness of anticoagulant therapy and to detect any potential drug-drug interactions. The test is typically performed in a laboratory setting, but can also be performed at the point-of-care using a portable device. The test is typically used in the management of patients with atrial fibrillation, deep vein thrombosis, and pulmonary embolism. The Rivaroxaban Test market is a rapidly growing segment of the point-of-care diagnostics industry. The test is becoming increasingly popular due to its convenience and accuracy. It is also becoming more widely available, with many hospitals and clinics now offering the test. Some of the companies in the Rivaroxaban Test market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, and Alere. Show Less Read more